Company intelligence / Profile preview
Galactica Pharmaceuticals
Villanova, Pennsylvania, USAgalacticapharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Galactica Pharmaceuticals is a platform company focused on developing RAGE fusion protein therapeutics for major diseases including COVID-19, diabetes complications, and macular degeneration. Their lead asset has shown promising preclinical results and they are preparing for clinical trials.
- Therapeutic areas
- OphthalmologyImmunologyEndocrinologyNeurologyInfectious Diseases
- Modalities
- Fusion proteins (specifically RAGE fusion protein)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Galactica Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Galactica Pharmaceuticals.